Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Mol Immunol ; 93: 246-252, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28886871

RESUMO

Decay accelerating factor (DAF or CD55) is a cell associated C3 and C5 convertase regulator originally described in terms of protection of self-cells from systemic complement but now known to modulate adaptive T cell responses. It is expressed on all cell types. We investigated whether nonenzymatic glycation could impair its function and potentially be relevant to complications of diabetes mellitus and other conditions that result in nonenzymatic glycation including cancer, Alzheimer's disease, and aging. Immunoblots of affinity-purified DAF from erythrocytes of patients with diabetes showed pentosidine, glyoxal-AGEs, carboxymethyllysine, and argpyrimidine. HPLC/MS analyses of glucose modified DAF localized the sites of AGE modifications to K125 adjacent to K126, K127 at the junction of CCPs2-3 and spatially near R96, and R100, all identified as being critical for DAF's function. Functional analyses of glucose or ribose treated DAF protein showed profound loss of its regulatory activity. The data argue that de-regulated activation of systemic complement and de-regulated activation of T cells and leukocytes could result from non-enzymatic glycation of DAF.


Assuntos
Antígenos CD55/química , Diabetes Mellitus/sangue , Produtos Finais de Glicação Avançada/química , Aminoácidos/química , Arginina/análogos & derivados , Arginina/análise , Antígenos CD55/sangue , Antígenos CD55/efeitos dos fármacos , Domínio Catalítico/efeitos dos fármacos , Ativação do Complemento , Eritrócitos/química , Glucose/farmacologia , Produtos Finais de Glicação Avançada/sangue , Humanos , Ativação Linfocitária , Lisina/análogos & derivados , Lisina/análise , Modelos Moleculares , Ornitina/análogos & derivados , Ornitina/análise , Conformação Proteica , Pirimidinas/análise , Ribose/farmacologia
4.
J Biol Chem ; 278(40): 38333-41, 2003 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-12876290

RESUMO

Tumor necrosis factor alpha (TNFalpha) expression is a key mediator of ethanol-induced liver disease. Increased lipopolysaccharide (LPS)-stimulated TNFalpha expression in macrophages after chronic ethanol feeding is associated with a stabilization of TNFalpha mRNA (Kishore, R., McMullen, M. R., and Nagy, L. E. (2001) J. Biol. Chem. 276, 41930-41937). Here we show that the 3'-UTR of murine TNFalpha mRNA was sufficient to mediate increased LPS-stimulated expression of a luciferase reporter in RAW 264.7 macrophages after chronic ethanol exposure. Further, we show that HuR, a nuclear/cytoplasmic shuttling protein, which binds to TNFalpha mRNA, is required for increased expression of TNFalpha after chronic ethanol. In Kupffer cells, HuR was primarily localized to the nucleus and then translocated to the cytosol in response to LPS in both pair- and ethanol-fed rats. After chronic ethanol feeding, HuR quantity in the cytosol was greater, both at baseline and in response to LPS, compared with pair-fed controls. Using RNA gel shift assays, we found that LPS treatment increased HuR binding to the 65-nucleotide A + U-rich element of the TNFalpha 3'-UTR by 2-fold over baseline in Kupffer cells from pair-fed rats. After chronic ethanol feeding, HuR binding to the TNFalpha A + U-rich element was increased by more than 5-fold at baseline and in response to LPS, compared with pair-fed controls. Down-regulation of HuR expression by RNA interference prevented the chronic ethanol-induced increase in expression of luciferase reporters containing the TNFalpha 3'-UTR. Taken together, these data demonstrate that increased binding of HuR to the TNFalpha 3'-UTR contributes to increased LPS-stimulated TNFalpha expression in macrophages after chronic ethanol exposure.


Assuntos
Antígenos de Superfície , Etanol/farmacologia , Macrófagos/metabolismo , Proteínas de Ligação a RNA/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Regiões 3' não Traduzidas , Animais , Western Blotting , Linhagem Celular , Núcleo Celular/metabolismo , Citosol/metabolismo , DNA/metabolismo , Relação Dose-Resposta a Droga , Proteínas ELAV , Proteína Semelhante a ELAV 1 , Eletroforese em Gel de Poliacrilamida , Escherichia coli/metabolismo , Imuno-Histoquímica , Células de Kupffer/metabolismo , Lipopolissacarídeos/metabolismo , Luciferases/metabolismo , Masculino , Camundongos , Modelos Genéticos , Regiões Promotoras Genéticas , Ligação Proteica , Transporte Proteico , RNA/metabolismo , Interferência de RNA , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Frações Subcelulares/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA